Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients
Zydus Lifesciences Ltd announced on Friday that it has attained final approval from the US health regulatory authority to produce and distribute its generic Isosorbide Mononitrate extended-release tablets. These tablets are utilized for preventing chest pain in patients with specific heart conditions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2024 Category: Pharmaceuticals Source Type: news
Imdur Tablets (isosorbide mononitrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 12, 2020 Category: Drugs & Pharmacology Source Type: news
Forensic epidemiologic analysis of the cause of an unexpected teen suicide following ingestion of mis-dispensed isosorbide mononitrate - Freeman MD.
A 17 year-old previously healthy male committed suicide approximately 1 day after ingesting isosorbide mononitrate, an organic nitrate drug used to treat symptoms of coronary artery disease. The drug had been mis-dispensed by a pharmacy in place of a presc... (Source: SafetyLit)
Source: SafetyLit - August 17, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
isosorbide mononitrate (Imdur, Ismo, Monoket)
Title: isosorbide mononitrate (Imdur, Ismo, Monoket)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/23/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 23, 2019 Category: Cardiology Source Type: news
Heart Meds May Prevent Vascular Dementia After Stroke Heart Meds May Prevent Vascular Dementia After Stroke
Cilostazol and isosorbide mononitrate have neuroprotective potential after lacunar stroke, which carries a high risk for vascular dementia and cognitive decline.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 6, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Drugs to prevent stroke and dementia show promise in early trial
Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study. The drugs - called cilostazol and isosorbide mononitrate - are already used to treat other conditions, such as heart disease and angina. This is the first time they have been tested in the UK for the treatment of stroke or vascular dementia. (Source: World Pharma News)
Source: World Pharma News - April 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Isosorbide Mononitrate Extended-Release Tablets, USP (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 19, 2019 Category: Drugs & Pharmacology Source Type: news
Monoket (Isosorbide Mononitrate, USP) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 28, 2017 Category: Drugs & Pharmacology Source Type: news
isosorbide mononitrate, Imdur, Ismo, Monoket
Title: isosorbide mononitrate, Imdur, Ismo, MonoketCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/10/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 10, 2017 Category: Cardiology Source Type: news
Ismo (Isosorbide Mononitrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 25, 2017 Category: Drugs & Pharmacology Source Type: news
Common medication for heart failure patients does not increase activity level
Heart failure patients with preserved ejection fraction -- where the heart becomes stiff and cannot relax or fill properly -- did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 9, 2015 Category: Science Source Type: news
NEAT-HFpEF: Activity Levels Fall on Nitrates in Preserved-EF HFNEAT-HFpEF: Activity Levels Fall on Nitrates in Preserved-EF HF
There wasn't much neat about treatment with isosorbide mononitrate in the small randomized trial; it didn't improve functional capacity or quality-of-life measures and may even have harmed. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 8, 2015 Category: Cardiology Tags: Cardiology News Source Type: news
Common medication for heart failure patients does not increase activity level
ORLANDO, Fla. — Heart failure patients with preserved ejection fraction (HFpEF) — where the heart becomes stiff and cannot relax or fill properly — did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo, according to a study presented today at the American Heart Association’s Scientific Sessions 2015. The findings come [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - November 8, 2015 Category: Hospital Management Source Type: news
Isosorbide Mononitrate Might Reduce Physical Activity in Heart Failure Patients with Preserved Ejection (FREE)
By Frederick A. Masoudi, MD, MSPH, FACC, FAHA
Dr. Masoudi is an associate editor with NEJM Journal Watch Cardiology, from which this story was adapted. See full coverage at the link below.Nitrates may adversely affect activity levels in patients with heart failure and preserved left ventricular ejection fraction, according to a multicenter, … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 8, 2015 Category: Primary Care Source Type: news
isosorbide mononitrate, Imdur, Ismo, Monoket
Title: isosorbide mononitrate, Imdur, Ismo, MonoketCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/30/2014 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 30, 2014 Category: Cardiology Source Type: news
